| Literature DB >> 26161728 |
David T Krist1, Alexander V Statsyuk1.
Abstract
Inactivation of the E6AP E3 ubiquitin ligase (UBE3A gene) causes Angelman syndrome, while aberrant degradation of p53 by E6AP is implicated in cervical cancers. Herein, we describe the development of photo-cross-linkers to discover catalytic residues of E6AP. Using these cross-linkers, we identified covalent modifications of the E6AP catalytic cysteine and two lysines: Lys(847) and Lys(799). Lys(847) is required for the formation of Lys(48)-linked polyubiquitin chains, while the K799A E6AP mutant was more active at producing Lys(48)-linked polyubiquitin chains. Thus, opposing roles of Lys(799) and Lys(847) pave the path forward to pharmacological inhibitors or activators of E6AP for therapeutic purposes.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26161728 PMCID: PMC4527872 DOI: 10.1021/acs.biochem.5b00625
Source DB: PubMed Journal: Biochemistry ISSN: 0006-2960 Impact factor: 3.162